Search - tctmd.com

Displaying 21 - 40 of 279

Sort: Relevancy | Date

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

Todd Neale

November 28, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Conference News ESC 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Yael L. Maxwell

September 10, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Daily News

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Yael L. Maxwell

August 08, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

Advertisement

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

December 2024 Dispatch for the CV Team

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

TCTMD’s Top 10 Most Popular Stories for August 2024

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

August 2024 Dispatch for the CV Team

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

July 2024 Dispatch for the CV Team

June 2024 Dispatch for the CV Team

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content